Raymond Cheung
Chartered Actuary · CRO · Board Adviser · Singapore
On 30 September 2026, MAS opened a consultation proposing to remove prior approval requirements for certain board and senior management appointments at lower-systemic-importance financial institutions. For insurance boards, the streamlining raises a sharper question than the headline suggests: when the regulator requires less approval, what does the board require of itself?
I've sat on insurance boards in Singapore when a board appointment has been caught in a prior-approval queue at MAS for months. The candidate is right for the role, the nominating committee has done its work, the CEO is waiting — and everyone is watching a regulatory process that feels procedural rather than substantive. So when MAS issued a consultation paper on 30 September 2026 proposing to remove prior approval requirements for certain board and senior management appointments at lower-systemic-importance financial institutions, my first reaction was: yes, that is sensible. My second reaction was a question the board itself needs to answer.
What MAS is actually proposing
The consultation covers four areas: director independence standards, board composition requirements, key appointments, and streamlined requirements for lower-impact FIs. The headline change is the last one — for financial institutions assessed as having less retail reach or lower systemic importance, MAS proposes to remove the requirement that certain board and senior management appointments receive MAS's prior approval before the individual takes up the role. The consultation closes 9 December 2026, and the proposals will reshape the Banking (Corporate Governance) Regulations 2005, the Insurance (Corporate Governance) Regulations 2013, and the FHC regulations for designated financial holding companies.
“Prior approval by a regulator was never a substitute for the board's own fit-and-proper assessment. When MAS does less of one, the board needs to do more of the other.”
The risk in this for insurance boards
The risk is not in what MAS is proposing. It is in how boards read it. Prior approval processes create a forcing function: the nominating committee has to produce a complete, documented case — fit and proper assessment, independence analysis, skills gap rationale — because the regulator will look at it. Remove the regulatory checkpoint, and some nominating committees will quietly reduce the rigour of the documentation. 'We don't need to submit for approval anymore' can slide, imperceptibly, into 'we don't need to do the substantive work as thoroughly.' That slide is the risk.
What insurance boards should do with this
- Treat the removal of MAS prior approval as a transfer of responsibility, not a reduction of obligation — the nominating committee's fit-and-proper assessment needs to be at least as rigorous as what was previously submitted to the regulator.
- Document the board's own assessment standards explicitly — what independence criteria the board applies, how it assesses fitness and propriety, and how it tests that assessment against MAS's published guidelines — and review those standards at least annually.
- The director independence provisions in the consultation are worth reading carefully: the proposals appear to tighten the substantive standards even as they streamline the process. An insurance board that has been comfortable with its independence classifications should re-examine them against the revised criteria once the consultation is finalised.
- Do not assume that 'lower-systemic-importance' classification means lower governance standard — it means MAS has assessed your regulatory footprint as lower risk; the board's own governance obligations remain unchanged.
The consultation is an opportunity for Singapore insurance boards to build something more durable than a prior-approval process: a nominating committee framework robust enough that regulatory oversight becomes the backstop, not the primary check. That is where board governance should be. MAS has opened the door. The boards that walk through it well will be the ones that make their own processes stronger, not the ones that treat the removal of a regulatory step as permission to simplify.
Common Questions
Which Singapore financial institutions are affected by MAS's September 2026 corporate governance consultation?
The consultation covers Singapore-incorporated banks, insurers, and designated financial holding companies. The proposed removal of prior approval for certain board and senior management appointments applies specifically to FIs assessed as having lower systemic importance or retail reach — MAS's risk-proportionate approach means not all insurers in scope for the Insurance (Corporate Governance) Regulations 2013 will be affected equally. The consultation closes 9 December 2026.
Does removing MAS's prior approval requirement reduce the governance standard for insurance board appointments?
No. It transfers responsibility. Where MAS previously reviewed documentation before an appointment took effect, the board's nominating committee will be the primary checkpoint. The substantive standard — fit and proper, independent assessment, documented rationale — remains. What changes is who reviews it first and with what consequence for timing. Boards that treat the change as a reduction in obligation rather than a transfer of responsibility are misreading it.
What does the MAS consultation propose on director independence for Singapore insurers?
The consultation includes proposals to update director independence standards as part of its targeted revisions to the Insurance (Corporate Governance) Regulations 2013. The full proposals are set out in MAS's consultation paper published 30 September 2026. Insurance boards should review the independence criteria provisions specifically, as tighter substantive standards may require re-examining existing board independence classifications — even as the process for approvals is streamlined.
About the author
Raymond Cheung is a Chartered Actuary, C-suite executive and board adviser with more than 20 years of experience across Asia in risk management, insurance, ESG and corporate governance. He is the CEO of CER Consultancy and an accredited trainer at SMU Academy and the Singapore College of Insurance.